Rutin / troxerutin
Rutin / Troxerutin (Vitamin P) · also known as Rutin, Rutoside, Vitamin P, Troxerutin, Troxerutin
Rutin and hydroxyethylrutoside (troxerutin) are flavonoid drugs traditionally used for capillary fragility and venous function. After oral intake they can be detected in human plasma, but the proposed mechanisms involving endothelial tight junctions, platelets and free radicals remain largely at the animal and in-vitro stage.
Clinical uses and human evidence
Varicose veins and leg swelling
Blood sugar and insulin resistance
Mechanisms of action
Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
A mouse dietary study showed that rutin improved intestinal ZO-1, occludin and claudin-1 expression after cold stress. The adherens junctions of capillary endothelium are different from the epithelial tight junctions discussed here. The effect of oral rutin on tight junction proteins in humans is still uncertain.
Platelet-activating factor (PAF) antagonism and improved microcirculatory rheology
In-vitro experiments on rabbit platelets showed that rutin, at concentrations of tens to hundreds of micromolar, can inhibit PAF-induced calcium responses. These concentrations are far above the exposure to unconjugated parent drug normally seen after oral dosing, and receptor-specific occupancy has not been demonstrated, so these results cannot currently be taken as evidence of an antiplatelet effect in humans.
Direct free radical trapping and chemical quenching
Cell-free experiments show that troxerutin can affect the capture signals for hydroxyl radicals and superoxide anion. After oral rutin, the main compounds detected in humans are quercetin and its conjugated metabolites. There is no human evidence on whether intact rutin directly scavenges superoxide or reduces lipid peroxidation in red blood cell membranes.